Cost-effectiveness of fondaparinux vs enoxaparin as prophylaxis against venous thromboembolism following orthopaedic surgery

被引：1
|
作者：
Posnett, J [1 ]
Gordois, A [1 ]
机构：
[1] Univ York, York YO10 5DD, N Yorkshire, England
来源：
VALUE IN HEALTH | 2002年 / 5卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)61196-5
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：444 / 444
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of fondaparinux vs. enoxaparin as venous thromboembolism prophylaxis in Sweden
    Jonas Lundkvist
    David Bergqvist
    Bengt Jönsson
    [J]. The European Journal of Health Economics, formerly: HEPAC , 2003, 4 (4): : 254 - 262
  • [2] COST-EFFECTIVENESS OF FONDAPARINUX VS ENOXAPARIN IN EXTENDED PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN MAJOR ORTHOPEDIC SURGERY IN POLAND
    Kawalec, P.
    Kuzma, J.
    Glogowski, C.
    Krzyzanowska, A.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A334 - A334
  • [3] The cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against thromboembolism following major orthopedic surgery
    Gordois, A
    Posnett, J
    Borris, L
    Bossuyt, P
    Jönsson, B
    Levy, E
    De Pouvourville, G
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (10) : 2167 - 2174
  • [4] Cost-effectiveness of extended venous thromboembolism prophylaxis with fondaparinux in major orthopaedic surgery in Switzerland
    Sendi, P
    Leuppi, JD
    [J]. VALUE IN HEALTH, 2004, 7 (06) : 732 - 733
  • [5] Cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against venous thromboembolism in patients undergoing hip fracture surgery
    Sullivan, SD
    Kwong, L
    Nutescu, E
    [J]. VALUE IN HEALTH, 2006, 9 (02) : 68 - 76
  • [6] A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism - Use in patients undergoing major orthopaedic surgery
    Sullivan, SD
    Davidson, BL
    Kahn, SR
    Muntz, JE
    Oster, G
    Raskob, G
    [J]. PHARMACOECONOMICS, 2004, 22 (09) : 605 - 620
  • [7] Cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against venous thromboembolism in patients undergoing major orthopedic surgery.
    Sullivan, SD
    Davidson, BL
    Kahn, SR
    Muntz, JE
    Oster, G
    Raskob, GE
    [J]. BLOOD, 2002, 100 (11) : 871A - 871A
  • [8] Cost-effectiveness of extending prophylaxis with fondaparinux in preventing venous thromboembolism following hip fracture surgery
    van Hout, BA
    Minjoulat-Rey, MC
    Quinlan, D
    Theeuwes, A
    Gabriel, S
    [J]. VALUE IN HEALTH, 2003, 6 (06) : 652 - 652
  • [9] A Cost-Effectiveness Analysis of Fondaparinux Sodium Compared with Enoxaparin Sodium as Prophylaxis Against Venous ThromboembolismUse in Patients Undergoing Major Orthopaedic Surgery
    Sean D. Sullivan
    Bruce L. Davidson
    Susan R. Kahn
    James E. Muntz
    Gerry Oster
    Gary Raskob
    [J]. PharmacoEconomics, 2004, 22 : 605 - 620
  • [10] Extended prophylaxis of venous thromboembolism with fondaparinux in patients undergoing major orthopaedic surgery in Italy: a cost-effectiveness analysis
    Stefano Capri
    Walter Ageno
    Davide Imberti
    Gualtiero Palareti
    Franco Piovella
    Gianluigi Scannapieco
    Marco Moia
    [J]. Internal and Emergency Medicine, 2010, 5 : 33 - 40
12345